The Japanese Journal of Antibiotics
Online ISSN : 2186-5477
Print ISSN : 0368-2781
ISSN-L : 0368-2781
CLINICAL EFFICACY OF AZTREONAM FOR REFRACTORY INFECTIONS IN CHILDREN
FUMIHIKO HAMADAHIDEO OGURAISAMU KITAMURAKENJI MATSUMOTOKUMIKO ARAKIMAKOTO KURAMITSUMIKIYA FUJIEDATAKANOBU KURASHIGEYUKIKO OGURA
Author information
JOURNAL FREE ACCESS

1985 Volume 38 Issue 11 Pages 3349-3357

Details
Abstract
Aztreonam (AZT) is the first monobactam antibiotic that has significant activity in vitro against aerobic Gram-negative bacteria but not against Gram-positive or anaerobic bacteria.
The agent was used 120-200mg/kg in daily dose to treat 10 hospitalized cases of refractory infections in pediatric field. There were 3 cases of 1 pneumonia, 4 cases of urinary tract infections, 2 cases of pyogenic meningitis and 1 case of septicemia.
Seven aerobic Gram-negative bacteria were isolated from patients and 4 bacteria were eradicated by treatment. Clinical cure was achieved in 8 out of 10 cases without adverse reaction or drug toxicity.
Content from these authors
© Japan Antibiotics Research Association
Previous article Next article
feedback
Top